• Meticulous Research®, a global leader in market research, has released its report titled “Artificial Intelligence in Genomics Market by Offering (Software, Services), Functionality (Sequencing, Gene Editing), Application (Diagnostics, Precision Medicine, Drug Discovery and Development), Delivery Mode (On-premises, Cloud) and End User—Global Forecast to 2029.”
According to the report, the global AI in genomics market is set to grow at a CAGR of 42.8% from 2022 to 2029, reaching $6.22 billion by the end of the period.
This growth is driven by the increasing application of AI in healthcare and genomics, rising investments in genomic research and AI, and efforts to reduce drug discovery and diagnostic turnaround times. The growing use of machine learning in personalized medicine and the emergence of AI and genomics startups are further fueling market growth.
Detailed Market Segmentation
The market is segmented by offering (software, services), delivery mode (on-premises, cloud & web-based), functionality (genome sequencing, gene editing, other functionalities), application (drug discovery and development, precision medicine, diagnostics, and other applications), end user (pharmaceutical & biopharmaceutical companies, academic & research institutes, and other end users), and geography. The report also assesses the competitive landscape and market shares of major players at both global and regional levels.
In 2022, the software segment is anticipated to lead the market by offering. This segment's high revenue is driven by subscription, licensed models, and SaaS, as well as ongoing technological advancements in AI for genomics.
The cloud & web-based delivery mode is expected to experience the fastest growth. The advantages of cloud-based/web-based offerings, such as cost savings, flexibility, automatic updates, and high data security, are driving their adoption among pharmaceutical & biopharmaceutical companies.
The genome sequencing segment is projected to dominate the market by functionality in 2022. AI-enhanced genomics software provides increased flexibility and effectiveness in genome sequencing, which helps identify disease genes and mutations, thus driving market growth.
Based on application, the drug discovery and development segment is expected to hold the largest market share in 2022. AI applications in drug discovery, such as modeling disease heterogeneity and optimizing drug candidates, are making the drug development process more efficient and cost-effective.
Pharmaceutical & biopharmaceutical companies are anticipated to account for the largest share of the market by end user in 2022. The integration of AI in genomics for drug discovery and precision medicine is driving demand, enabling these companies to accelerate the drug discovery process and reduce costs.
The report provides a comprehensive analysis of key geographic regions, including North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa.
North America is expected to lead the global AI in genomics market in 2022, with the U.S. accounting for the largest share. This growth is driven by substantial public and private investments in genomics and the increasing use of AI in precision medicine.
Key Players
The key players operating in the global AI in genomics market are Microsoft Corporation (U.S.), NVIDIA Corporation (U.S.), Deep Genomics Incorporated (Canada), Fabric Genomics, Inc. (U.S.), Data4Cure, Inc. (U.S.), Predictive Oncology Inc. (U.S.), Emedgene Technologies LTD (U.S.), Congenica Ltd. (U.K.), Tempus Labs, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Illumina Inc. (U.S.), and BenevolentAI Limited. (U.K.).

Download Sample Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5345
Key questions answered in the report-
• Which are the high-growth market segments in terms of offering, delivery mode, functionality, application, end user, and geography?
• What was the historical market for AI in genomics across the globe?
• What are the market forecasts and estimates for the period 2022–2029?
• What are the major drivers, restraints, opportunities, and challenges in the global AI in genomics market?
• Who are the major players in the global Artificial Intelligence in genomics market?
• How is the competitive landscape, and who are the market leaders in the global AI in genomics market?
• What are the recent developments in the AI in genomics market?
• What are the different strategies adopted by the major players in the AI in genomics market?
• What are the geographic trends and high growth regions/countries?
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research